🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

ALKALI vs NOCIL: Stock Comparison

ALKALI vs NOCILUpdated 24 Sept 26, 4:08 PM ISTNSE & company filings

NOCIL is the larger company by market capitalisation. ALKALI shows a higher dividend yield and faster revenue growth, while NOCIL shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALKALI leads 5; NOCIL leads 6 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALKALINOCIL

Valuation lens

What price are you paying?

Market CapContext only
₹76 Cr
₹2,335 Cr
P/E RatioSame reading
—
36.78x
P/B RatioSame reading
—
1.37x
EPSNOCIL has the higher reading
₹0.57
₹1.66 ✓
Book ValueContext only
₹43.89
₹106.18
Dividend YieldALKALI has the higher reading
1.35% ✓
1.03%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NOCIL is the larger company
₹2,335 Cr vs ₹76 Cr
EPS
NOCIL has higher earnings per share
₹1.66 vs ₹0.57
Dividend Yield
ALKALI has a higher dividend yield
1.35% vs 1.03%
Revenue Growth (TTM YoY)
ALKALI has faster revenue growth
2.98% vs -2.8%
EPS Growth (TTM YoY)
ALKALI has faster EPS growth
0% vs -19.2%
Qtr Sales Growth
ALKALI has stronger quarterly sales growth
55.23% vs 0%
Qtr Profit Growth
ALKALI has stronger quarterly profit growth
189.37% vs 0%
ROE
NOCIL has a higher ROE
3.14% vs 1.25%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALKALINOCIL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricALKALINOCIL
Live Price₹96.37₹140.05
Day Change-5.18%-3.65%
Volume55,36111.08 L
52-Week High₹106.3₹211.2
52-Week Low₹46.8₹125.31
Distance from 52W High-9.34%-33.69%

Valuation

MetricALKALINOCIL
Market Cap₹76 Cr₹2,335 Cr
P/E Ratio—36.78x
P/B Ratio—1.37x
EPS₹0.57₹1.66
Book Value₹43.89₹106.18
Dividend Yield1.35%1.03%

Growth

MetricALKALINOCIL
Revenue Growth (TTM YoY)2.98%-2.8%
EPS Growth (TTM YoY)0%-19.2%
Qtr Sales Growth55.23%0%
Qtr Profit Growth189.37%0%

Profitability & Leverage

MetricALKALINOCIL
ROE1.25%3.14%
ROCE1.46%3.61%
Net Margin0.6%4.86%
Operating Margin5.86%5.94%
Debt to Equity0.4x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricALKALINOCIL
Promoter Holding68.51%33.76%
FII Holding0%5.28%▲ 0.5 pp
DII Holding0%6.96%▼ 0.51 pp
Public Holding30.41%53.99%▲ 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALKALI and NOCIL.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.